METTL16 and breast carcinoma: Recent studies have revealed that RNA m6A modification contributes to breast cancer development, with the novel m6A methyltransferase METTL16 implicated in regulating key gene expression and signaling pathways, thereby affecting tumor cell proliferation, metastasis, and therapeutic sensitivity.